Alerts will be sent to your verified email
Verify EmailBACPHAR
|
Bacil Pharma
|
Veerhealth Care
|
Biofil Chem & Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.32 % | 2.69 % | 4.39 % |
|
5yr average Equity Multiplier
|
1.36 | 1.35 | 2.06 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.51 | 0.95 |
|
5yr Avg Net Profit Margin
|
0.0 | 3.95 % | 2.38 % |
|
Price to Book
|
2.34 | 2.53 | 2.69 |
|
P/E
|
37.42 | 106.41 | 20.64 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 43.62 Days | 75.63 Days |
|
Inventory Days
|
0.0 | 56.8 Days | 28.27 Days |
|
Days Receivable
|
0.0 | 78.02 Days | 389.8 Days |
|
Days Payable
|
0.0 | 63.05 Days | 203.89 Days |
|
5yr Average Interest Coverage Ratio
|
-943.72 | 208.02 | 23.53 |
|
5yr Avg ROCE
|
-75.56 % | 3.74 % | 6.37 % |
|
5yr Avg Operating Profit Margin
|
0.0 | 0.37 % | 3.78 % |
|
5 yr average Debt to Equity
|
0.05 | 0.07 | 0.03 |
|
5yr CAGR Net Profit
|
n/a | 0.52 % | -14.7 % |
|
5yr Average Return on Assets
|
-70.2 % | 2.06 % | 2.37 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 31.5 % | 46.79 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-42.67 % | 0.74 % | -0.03 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Bacil Pharma
|
Veerhealth Care
|
Biofil Chem & Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|